09/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

09/2024

Sep 20, 2024, 14:04 | Dialogues
ASCO24 Updates: Jonathan Nascimento Priantti on osimertinib's Efficacy in Uncommon EGFR Mutations | OncoDaily
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Sep 20, 2024, 14:01 | Blog
Zainab Shinkafi-Bagudu: Gathering advocates to discuss Cervical Cancer at WHO HQ
Zainab Shinkafi-Bagudu posted the following on LinkedIn: “At the WHA 77 in May 2024, a…
Sep 20, 2024, 13:57 | Blog
Adrian Lee: Addressing breast cancer data underutilization with Estrogene2.0
Adrian Lee, Director, Insitute for Precison Medicine at UPMC, posted the following on LinkedIn: “When researchers…
Sep 20, 2024, 13:55 | Blog
Wungki Park: Successful meeting at ESMO24
Wungki Park, Gastrointestinal Oncologist at the Memorial Sloan Kettering Cancer Center, posted on X: "Barcelona always…
Sep 20, 2024, 13:49 | Blog
Lisa A. Lacasse: Honoring outstanding National Advocacy Leadership Awardees
Lisa A. Lacasse shared a post by American Cancer Society Cancer Action Network on LinkedIn,…
Sep 20, 2024, 13:45 | Blog
Join European Cancer Organisation for an interactive morning of sessions in Brussels
European Cancer Organisation posted the following on LinkedIn: “Join us for a morning of interactive,…
Sep 20, 2024, 13:42 | Blog
Isabel Mestres: C/Can team comes together in person to deepen connections and leadership
Isabel Mestres posted the following on LinkedIn: “What happens when a team of passionate changemakers…
Sep 20, 2024, 13:37 | Blog
Chandler Park: Outstanding discussion on the Niagara study by Petros Grivas
Chandler Park posted the following on X: “OUTSTANDING balanced discussion of the Niagara study by…
Sep 20, 2024, 13:33 | Blog
Miriam Mutebi: Arrival at UICC World Cancer Congress
Miriam Mutebi posted the following on LinkedIn: “It’s been a couple of awake hours since…
Sep 20, 2024, 13:27 | Blog
Stephen V Liu: FDA approved MARIPOSA2
Stephen V Liu shared on X: “FDA approved MARIPOSA2: amivantamab plus chemotherapy for EGFR NSCLC…
All: 2507 Posts: 891 - 900
Special Coverage